SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-17-001511
Filing Date
2017-03-14
Accepted
2017-03-14 16:28:57
Documents
1
Period of Report
2017-03-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_empfield031417.html 4  
1 OWNERSHIP DOCUMENT f4_empfield031417.xml 4 3984
  Complete submission text file 0001171843-17-001511.txt   5317
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 VG5 48W
Business Address
EMPFIELD JAMES R. (Reporting) CIK: 0001665430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 17688402